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Claspin is necessary for the ATR-dependent activa-
tion of Chk1 in Xenopus egg extracts containing incom-
pletely replicated DNA. ATR possesses a regulatory
partner called ATRIP. We have studied the respective
roles of ATR-ATRIP and Claspin in the activation of
Chk1. ATR-ATRIP bound well to various DNA templates
in Xenopus egg extracts. ATR-ATRIP bound to a single-
stranded DNA template was weakly active. By contrast,
the ATR-ATRIP complex on a DNA template containing
both single- and double-stranded regions displayed a
large increase in kinase activity. This observation sug-
gests that ATR-ATRIP normally undergoes activation
upon association with specific nucleic acid structures at
DNA replication forks. Without Claspin, activated ATR-
ATRIP phosphorylated Chk1 weakly in a cell-free reac-
tion. The addition of Claspin to this reaction strongly
stimulated the phosphorylation of Chk1 by ATR-ATRIP.
Claspin also induced significant autophosphorylation of
Chk1 in the absence of ATR-ATRIP. Taken together,
these results indicate that the checkpoint-dependent
phosphorylation of Chk1 is a multistep process involv-
ing activation of the ATR-ATRIP complex at replication
forks and presentation of Chk1 to this complex by
Claspin.
In eukaryotic cells, various checkpoint control mechanisms
guard the integrity of the genomic DNA. These regulatory
pathways prevent mitotic entry when cells experience prob-
lems with DNA replication or suffer DNA damage (for reviews,
see Refs. 1–3). These biochemical networks contain sensor pro-
teins that monitor the presence of specific nucleic acid struc-
tures and/or associated proteins at sites of DNA replication or
DNA damage. The sensor proteins regulate effector proteins,
which in turn control cell cycle progression and other processes.
A third class of proteins, termed mediators or adaptors, may
promote functional interactions between sensor and effector
proteins. Certain checkpoint proteins may carry out more than
one of these functions.
The process by which cells detect incompletely replicated
DNA in the genome can be studied in cell-free extracts from
Xenopus eggs (4–6). Treatment of these extracts with the DNA
polymerase inhibitor aphidicolin results in accumulation of
stalled DNA replication forks. These replication blockages
elicit activation of Xchk1, the Xenopus version of the check-
point effector kinase Chk1 (6). In vertebrates, the activation of
Chk1 requires ATR, which is a member of the phosphoinositide
kinase-related family of proteins (7–10). In egg extracts, Xeno-
pus ATR (Xatr) catalyzes the stimulatory phosphorylation of
Xchk1 at multiple conserved (S/T)Q sites in its regulatory do-
main (7). The activated form of Chk1 blocks the initiation of
mitosis by preventing activation of the Cdc2-cyclin B complex
in a wide range of organisms (reviewed in Refs. 1 and 11).
The Xatr-catalyzed phosphorylation of Xchk1 also requires
another protein named Claspin (12–15). Because Claspin asso-
ciates directly with Xchk1, Claspin may promote the phospho-
rylation of Xchk1 by Xatr by serving as a mediator or adaptor
protein. Claspin also interacts with chromatin in a highly spe-
cific manner during the course of DNA replication in egg ex-
tracts (15). The binding of Claspin to chromatin depends upon
various proteins involved in the initiation of DNA replication,
including the pre-replication complex, Cdc45, and Cdk2. These
observations imply that Claspin also detects the presence of
active DNA replication forks in the nucleus as part of its
function. Functional relatives of Claspin in budding and fission
yeast called Mrc1 appear to fulfill a similar role in these or-
ganisms (16–19).
In addition to Claspin and Mrc1, various other proteins fall
into the mediator/adaptor class. For example, in budding yeast,
Rad9 is required for activation of the checkpoint effector kinase
Rad53 in response to DNA damage (see Refs. 1–3). In fission
yeast, a relative of Rad9 called Crb2 appears to play a similar
role in the DNA damage-dependent activation of Chk1. Rad9
and Crb2 both possess conserved BRCA1 C-terminal domains,
which generally dock with other proteins in a phosphorylation-
dependent manner (20). In vertebrates, potential functional
relatives of these proteins include 53BP1, TopBP1/Cut5, Mdc1,
and BRCA1 itself (21). Significantly, Claspin and Mrc1 do not
contain BRCA1 C-terminal motifs, suggesting that the various
checkpoint mediator/adaptor proteins have distinct functional
properties.
The correct regulation of Chk1 also depends on a number of
other proteins. For example, ATR possesses a binding partner
called ATRIP that is important for the association of ATR with
DNA (22). In addition, checkpoint clamp loader and checkpoint
sliding clamp proteins participate in the detection of incom-
pletely replicated/damaged DNA (reviewed in Refs. 1–3). For
example, Rad17 forms a clamp loader complex with the four
small subunits of replication factor C (RFC2–5). The Rad17-
RFC2–5 complex enables the binding of a clamp consisting of
Rad9, Rad1, and Hus1 (the 9-1-1 complex) to checkpoint-induc-
ing DNA templates.
A key question is how various checkpoint regulatory proteins
collaborate in the activation of downstream effector kinases
such as Chk1. Although proteins like Claspin have been re-
ferred to as adaptors or mediators that facilitate the ability of
upstream kinases in the ATR/ATM family to phosphorylate
downstream checkpoint effector kinases, there has been no
direct biochemical evidence that these proteins function in this
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manner. In this study, we have used a reconstituted system to
directly evaluate the concept that Claspin promotes the phos-
phorylation of Chk1 by ATR.
EXPERIMENTAL PROCEDURES
Xenopus Egg Extracts—Xenopus egg extracts as well as nuclear and
chromatin fractions from these extracts were prepared as described
previously (6, 12, 15).
Activation of Xchk1 and Xchk2 in Egg Extracts—The use of single-
stranded (dA)70 and (dA)70 annealed to (dT)70 ((dA)70-(dT)70) to study
checkpoint responses in Xenopus egg extracts was described previously
(12). The oligonucleotide CGGAAGGGCCGAGCGCAGAAGTGGTCCT-
GCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGG was
used as a random sequence single-stranded 70-mer. This oligonucleo-
tide was annealed to its complementary sequence to yield a random
sequence double-stranded 70-mer. The oligonucleotide CTAGTG-
CACGCTAGAGGCAAGTGGGTACTGGAGCTCCATA and its comple-
mentary sequence were used to form a random sequence double-
stranded 40-mer. Typically, we added oligonucleotides at a final
concentration of 50 g/ml to the extracts. To observe phosphorylation of
Xchk1 and Xchk2, we incubated the extracts in the presence or absence
of 3 M tautomycin, respectively, in addition to the appropriate DNA
template.
Cloning of cDNA Encoding Xenopus ATRIP (Xatrip)—A Xenopus
expressed sequence tag (TC177046) with significant homology to hu-
man ATRIP was identified. Using primers based on this sequence, a
DNA fragment was isolated by PCR from a Xenopus oocyte cDNA
library. This fragment was used as a probe to isolate a 2.9-kb cDNA
encoding full-length Xatrip with the ClonCapture kit (Clontech). DNA
sequencing of this cDNA was performed at the California Institute of
Technology Sequencing Facility.
Production of Recombinant Proteins—The coding sequence of Xatrip
was cloned into pFastBacHTa, and a sequence encoding a FLAG epitope
was engineered into the 3-end of the coding sequence by standard
procedures. The His6-Xatrip-FLAG protein, with His6 and FLAG tags at
the N- and C-terminal ends, respectively, was produced in Sf9 insect
cells and purified with nickel-agarose beads as described (12). Recom-
binant Xchk1-GST1-His6 proteins, with GST and His6 tags at the C-
terminal end, were prepared in a similar manner (12). Recombinant
human RPA was produced in Escherichia coli CodonPlus RIL cells and
purified as described (23).
Production of Antibodies—Anti-Xatr antibodies were produced
against a bacterially expressed His6-tagged fragment of Xatr (amino
acids 403–823). Anti-Xatrip antibodies were produced against His6-
tagged full-length Xatrip expressed in Sf9 insect cells. Antibodies were
raised in rabbits at a commercial facility and affinity-purified with the
original antigen.
Immunodepletions from Egg Extracts—Xatr, Xatrip, and Claspin
were immunodepleted from egg extracts with antibodies bound to pro-
tein A-conjugated magnetic beads (Dynal, Inc.) as described (15). Two
rounds of immunodepletion were performed to ensure complete removal
of the protein.
Binding of Purified His6-Xatrip-FLAG to Oligonucleotides—Purified
His6-Xatrip-FLAG protein was incubated for 30 min at 4 °C with mag-
netic beads coated with (dA)70, (dA)70-(dT)70, or no DNA in the absence
and presence of recombinant human RPA in buffer A (10 mM HEPES-
KOH (pH 7.5), 80 mM NaCl, 20 mM -glycerol phosphate, 2.5 mM EGTA,
and 0.1% Nonidet P-40) containing 10 mM MgCl2, 100 g/ml bovine
serum albumin, and 10 mM dithiothreitol. After the incubation, the
beads were washed four times with buffer A. Bound proteins were
eluted with SDS gel sample buffer.
Isolation of Xatr Bound to Magnetic Beads Containing Oligonucleo-
tides—Streptavidin-conjugated magnetic beads (Dynal, Inc.) containing
biotinylated (dA)70 or (dA)70-(dT)70 were incubated for 60 min in inter-
phase egg extract. The biotin group was attached to the 5-end of (dA)70.
In the case of (dA)70-(dT)70, only (dA)70 was biotinylated. Magnetic
beads were washed three times by centrifugation for 3 min at 2070  g
through 1 M sucrose dissolved in 20 mM HEPES-KOH (pH 7.5), 80 mM
KCl, 2.5 mM potassium gluconate, and 10 mM magnesium gluconate.
Next, the beads were washed by collection with a magnetic rack twice
with buffer A and once with 20 mM HEPES-KOH (pH 7.5).
Assay for the Kinase Activity of Xatr-Xatrip—Streptavidin-conju-
gated magnetic beads containing biotinylated (dA)70 or (dA)70-(dT)70
(2.5 g) were incubated in interphase egg extract (100 l) for 60 min.
For the extracts containing beads with (dA)70-(dT)70, we also added a
soluble random sequence double-stranded 40-mer (2.5 g/100 l of
extract) to increase the binding of Xatr-Xatrip to the beads. The addi-
tion of the random sequence double-stranded 40-mer to extracts con-
taining (dA)70-coated magnetic beads had no effect on the activity of
Xatr-Xatrip isolated from these extracts (data not shown). Magnetic
beads containing associated Xatr-Xatrip were isolated as described
above and treated with 25 units of micrococcal nuclease (Worthington)
at room temperature for 15 min in 50 l of 50 mM Tris-HCl (pH 7.5), 100
mM NaCl, 2 mM CaCl2, 0.5 mM phenylmethylsulfonyl fluoride, 10 g/ml
pepstatin, 10 g/ml leupeptin, and 10 g/ml chymostatin. Proteins that
were released from the beads by nuclease treatment were collected and
mixed with 50 l of buffer A containing 100 g/ml ethidium bromide.
The Xatr-Xatrip complex was immunoprecipitated with anti-Xatrip an-
tibodies (1 g) bound to protein A beads (10 l). The kinase activity of
Xatr was assayed with PHAS-I as the substrate as described (7). Kinase
assays with Xchk1-GST-His6 as the substrate were performed in the
presence of 1 mM nonradioactive ATP.
Production of Recombinant Xchk1-GST-His6 Associated with Claspin
from Egg Extracts—Interphase egg extracts (100 l) containing either
(dA)70 alone or (dA)70-(dT)70 plus 3 M tautomycin were incubated for 60
min at room temperature. After 60 min, 200 l of buffer containing 10
mM HEPES-KOH (pH 7.5), 0.1% CHAPS, 20 mM EDTA, 2.5 mM EGTA,
and 20 mM -glycerol phosphate was added to the extracts, and the
mixtures were centrifuged through Sephadex G-25 spin columns equil-
ibrated with the same buffer. Recombinant Xchk1-GST-His6 proteins (1
g) were incubated in the excluded spin-through fractions from the
columns for 1 h at 4 °C and then isolated from the incubations with
glutathione-agarose beads.
RESULTS
Xatr Is Required for the Phosphorylation of Xchk1 in Re-
sponse toModel DNATemplates—Xchk1 undergoes checkpoint-
dependent phosphorylation in response to incompletely repli-
cated DNA in Xenopus egg extracts (6). This phosphorylation
depends upon Xatr (7, 9). For these experiments, the DNA
polymerase inhibitor aphidicolin was used to induce the forma-
tion of DNA replication blocks in Xenopus sperm chromatin
that had been incorporated into reconstituted nuclei (4, 6). The
phosphorylation of Xchk1 can also be triggered by the addition
of certain defined DNA templates to egg extracts. For example,
annealed oligomers consisting of (dA)70 and (dT)70 are very
effective for this purpose (12). Given their relatively simple
nature in comparison with reconstituted sperm chromatin, we
wanted to use such templates to investigate the biochemical
properties of the checkpoint pathway containing Xatr, Claspin,
and Xchk1.
To pursue this line of investigation, we first characterized
the features of the DNA templates that are important for
inducing activation of Xchk1. As shown in Fig. 1A, (dA)70-(dT)70
induced the phosphorylation of Xchk1 very efficiently, as de-
scribed previously (12). We also observed that a longer tem-
plate consisting of (dA)100-(dT)100 gave similar results (data not
shown). Random sequence double-stranded 70-mers likewise
elicited strong phosphorylation of Xchk1, although not quite as
well as (dA)70-(dT)70. By comparison, annealed 40-mers of
poly(dA) and poly(dT) or annealed 40-mers of random sequence
oligonucleotides were typically significantly less effective at
triggering the phosphorylation of Xchk1. Finally, single-
stranded (dA)70 and a random sequence single-stranded 70-
mer did not cause significant phosphorylation of Xchk1. In
parallel, we also examined the effects of the various oligonu-
cleotides on the phosphorylation of Xchk2 (Fig. 1A). Xchk2
became maximally phosphorylated in response to all of the
double-stranded templates, regardless of length, but not in
response to the single-stranded templates.
In other experiments with various more complex templates
containing three or four oligonucleotides that were designed
explicitly to mimic features of replication forks, we could not
identify any template that was markedly better than (dA)70-
1 The abbreviations used are: GST, glutathione S-transferase; RPA,
replication protein A; CHAPS, 3-[(3-cholamidopropyl)dimethylammo-
nio]-1-propanesulfonic acid.
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(dT)70 for inducing the phosphorylation of Xchk1 (data not
shown). Therefore, we used this template for most of the ex-
periments in this study.
First, we asked whether the phosphorylation of Xchk1 that is
induced by (dA)70-(dT)70 also depends upon Xatr. To investi-
gate this issue, we removed Xatr from egg extracts by immu-
nodepletion with anti-Xatr antibodies (Fig. 1B). In parallel, we
used control antibodies to prepare mock-depleted extracts. We
incubated the depleted extracts with (dA)70 or (dA)70-(dT)70 in
the presence of an exogenously added recombinant Xchk1-GST-
His6 protein. Finally, we recovered Xchk1-GST-His6 from the
extracts and examined its phosphorylation state by immuno-
blotting with anti-GST antibodies. In mock-depleted extracts,
Xchk1 underwent strong phosphorylation in the presence of
(dA)70-(dT)70, but not (dA)70, consistent with previous results
(12). By contrast, in Xatr-depleted extracts, there was no phos-
phorylation of Xchk1-GST-His6 in the presence of (dA)70-(dT)70.
These results indicate that (dA)70-(dT)70 induces a checkpoint
response that is controlled by Xatr as the upstream regulator.
Identification of Xatrip, a Xenopus Homolog of ATRIP—In all
known cases, ATR and its homologs form a complex with a
specific binding partner or regulatory subunit. This protein
was first described in fission yeast as Rad26, which interacts
with Rad3, the fission yeast equivalent of ATR (24, 25). In
Aspergillus nidulans, the uvsB and uvsD genes encode ATR
and Rad26 homologs, respectively (26). Three groups identified
a homolog of Rad26 in budding yeast named Ddc2, Lcd1, and
Pie1, respectively (27–29). Ddc2/Lcd1/Pie1 interacts with
Mec1, the budding yeast homolog of ATR. Most recently, this
protein was identified in human cells and named ATRIP (ATR-
interacting protein) (30). To study Xatr along with its pre-
sumed binding partner, we isolated a cDNA that encodes a
Xenopus homolog of this ATR-binding protein from an oocyte
library (Fig. 2). We named this protein Xenopus ATRIP (Xatrip)
because, among known counterparts, it is most similar to hu-
man ATRIP. Overall, Xatrip is 45% identical at the amino acid
level to human ATRIP, but there are two regions with higher
homology (amino acids 62–277 and 566–801) that are more
than 50% identical between the two species. In these regions,
there are four conserved serine and threonine residues (amino
acids 84, 88, 197, and 741) in (S/T)Q motifs that are potential
phosphorylation sites for ATR. There is also a predicted coiled-
coil domain in the N-terminal conserved region (amino acids
128–243). Xatrip has low homology to a potential functional
counterpart in Drosophila called MUS304 (25% identical).
However, Xatrip shows minimal primary sequence homology to
fission yeast Rad26 and budding yeast Ddc2/Lcd1/Pie1.
Xatr and Xatrip Form a Tight Complex That Associates with
DNA—To study the properties of Xatrip, we raised antibodies
against full-length recombinant His6-Xatrip that had been ex-
pressed in baculovirus-infected insect cells. In immunoblotting
experiments, the antibodies recognized a 100-kDa polypeptide
in egg extracts (Fig. 3A). Using recombinant Xatrip as a stand-
ard, we estimated that the concentration of endogenous Xatrip
in the egg extract was 40 nM. For comparison, the concentra-
tion of Xatr was56 nM. The amounts of Xatrip and Xatr in egg
extracts did not appear to change during the course of the cell
cycle or upon checkpoint activation (data not shown).
To assess whether Xatr and Xatrip form a complex in egg
extracts, we performed immunoprecipitation studies. As shown
in Fig. 3A, we could readily detect Xatr in anti-Xatrip immu-
noprecipitates. Moreover, we could use anti-Xatr antibodies to
immunoprecipitate Xatrip efficiently. The interaction between
Xatr and Xatrip persisted after extensive washing with buffer
containing 150 mM NaCl and 0.5% Nonidet P-40, indicating
that these proteins form a stable complex. The binding of Xatr
to Xatrip did not change during progression of the cell cycle
(data not shown) or after the addition of either (dA)70 or (dA)70-
(dT)70 to the egg extracts (Fig. 3B).
Next, we examined the DNA binding properties of Xatr-Xatrip.
For this purpose, we first utilized streptavidin-conjugated mag-
netic beads that had been coated with various biotinylated oligo-
nucleotides. Beads containing (dA)70, (dA)70-(dT)70, or no DNA
were incubated in egg extracts, re-isolated from the extracts, and
analyzed for the presence of Xatr and Xatrip by immunoblotting.
We observed that both Xatr and Xatrip associated with (dA)70
and (dA)70-(dT)70, but binding to single-stranded (dA)70 was
much greater (Fig. 3C). There was no binding of either protein to
beads lacking DNA.
To characterize further the binding of Xatr and Xatrip to
single-stranded DNA in egg extracts, we used single-stranded
poly(dA) of different lengths on magnetic beads (Fig. 3D). As
expected, Xatr and Xatrip bound well to (dA)70 in egg extracts.
Furthermore, both proteins associated efficiently with poly(dA)
that was 40, 30, or 20 nucleotides in length. By contrast, there
was no detectable binding of either Xatr or Xatrip to a 10-mer
of poly(dA). These results indicate that Xatr can associate with
relatively short stretches of single-stranded DNA as small as
20 nucleotides in length. However, even 70-mers of single-
stranded DNA were ineffective in eliciting the phosphorylation
of Xchk1 (see Fig. 1A). Therefore, the association of Xatr with
FIG. 1. Xatr is required for the phosphorylation of Xchk1 in-
duced bymodel DNA templates. A, 35S-labeled Xchk1 was incubated
in egg extracts containing no DNA (lane 1), (dA)70 (lane 2), random
sequence single-stranded (ss) 70-mer DNA (lane 3), pre-annealed
(dA)40-(dT)40 (lane 4), pre-annealed (dA)70-(dT)70 (lane 5), random se-
quence double-stranded (ds) 40-mer DNA (lane 6), and random se-
quence double-stranded 70-mer DNA (lane 7). DNA templates were
added to a final concentration of 50 g/ml, and all incubations also
contained 3 M tautomycin. After 60 min, aliquots were removed for
SDS-PAGE and phosphorimaging (upper panel). In parallel, the same
set of extracts was incubated without 35S-labeled Xchk1 in the absence
of tautomycin and immunoblotted for endogenous Xchk2 (lower panel).
Three experiments (upper panel) and two experiments (lower panel)
gave similar results. B, egg extracts (lane 1) were subjected to mock
immunodepletion with control antibodies (lane 2) or to immunodeple-
tion with anti-Xatr antibodies (lane 3). The extracts were immuno-
blotted with anti-Xatr antibodies (lanes 1–3). Recombinant Xchk1-GST-
His6 (Xchk1-GH) protein was added to mock-depleted (lanes 4 and 5)
and Xatr-depleted (Xatr; lanes 6 and 7) extracts and incubated for 100
min in the presence of (dA)70 (A; lanes 4 and 6) or (dA)70-(dT)70 (AT;
lanes 5 and 7). Xchk1-GST-His6 protein was subsequently recovered
with glutathione-agarose and immunoblotted with anti-GST antibod-
ies. Three independent experiments yielded similar results.
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single-stranded DNA is by itself not sufficient to elicit a check-
point response.
Since a random sequence double-stranded 40-mer oligonu-
cleotide template triggered the activation of Xchk2 preferen-
tially compared with that of Xchk1, we asked whether the
addition of a soluble double-stranded 40-mer to egg extracts
would affect the binding of Xatr and Xatrip to biotinylated
(dA)70-(dT)70 on magnetic beads. Interestingly, the presence of
a double-stranded 40-mer in the egg extracts resulted in in-
creased binding of Xatr-Xatrip to beads containing (dA)70-
(dT)70, but not (dA)70 (Fig. 3C). An explanation for this obser-
vation would be that the double-stranded 40-mer acts as a
competitor for proteins that preferentially recognize double-
stranded DNA ends. Consistent with this possibility, the addi-
tion of the double-stranded 40-mer reduced the binding of the
DNA-dependent protein kinase, Ku70, and Ku80 to (dA)70-
(dT)70 on magnetic beads.
2 In the experiments described below,
we used this competitor DNA to increase the yield of Xatr-
Xatrip that could be obtained from egg extracts through bind-
ing to magnetic beads coated with (dA)70-(dT)70.
Finally, we asked whether Claspin associates with any of the
oligonucleotide templates. We could not detect any binding of
Claspin to (dA)70 or (dA)70-(dT)70 in either the absence or
presence of the double-stranded 40-mer (Fig. 3C). Therefore,
although Claspin binds quite well to stalled replication forks in
chromosomal DNA (15), we could not detect stable association
of Claspin with model DNA templates that trigger the activa-
tion of Xchk1, at least under these conditions.
Role of Xatrip in the Binding of Xatr to DNA—Next, we
examined the functional properties of Xatrip in egg extracts.
For these experiments, we attempted to remove Xatrip from
the extracts by immunodepletion with anti-Xatrip antibodies.
As shown in Fig. 4A, all of the Xatrip could be removed by this
procedure. Significantly, 30% of the Xatr remained behind in
the Xatrip-depleted extract. In parallel, we also removed Xatr
from the extracts with anti-Xatr antibodies. This procedure
resulted in the elimination of not only Xatr but also all of the
Xatrip from the extracts. These observations indicate that all of
the Xatrip in the egg extracts was associated with Xatr. How-
ever, since there was an excess of Xatr over Xatrip in the egg
extracts, 30% of the total Xatr was not bound to Xatrip.
We proceeded to examine whether Xatr could bind to DNA2 S.-M. Kim, H. Y. Yoo, and W. G. Dunphy, unpublished data.
FIG. 2. Sequence alignment of Xatrip and human ATRIP. Identical and conserved residues are shaded in black and gray, respectively.
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oligonucleotides on magnetic beads in the absence of Xatrip.
Consistent with the results described above, we could readily
detect both Xatr and Xatrip on magnetic beads containing
(dA)70 or (dA)70-(dT)70 that had been incubated in mock-de-
pleted extracts (Fig. 4, B and C). By contrast, even though a
substantial amount of Xatr remained behind in the Xatrip-
depleted extracts, we could not detect any binding of Xatr to
(dA)70-(dT)70 in these extracts. This observation suggests that
Xatr needs Xatrip to associate stably with either single- or
double-stranded oligonucleotides.
Various observations have indicated that RPA is necessary
for the recruitment of ATR to stalled replication forks (15, 22,
31, 32). Therefore, we asked whether RPA is required for the
binding of Xatrip to DNA oligonucleotides. For this experiment,
we incubated recombinant His6-Xatrip-FLAG with magnetic
beads containing no DNA, (dA)70, or (dA)70-(dT)70 in the ab-
sence and presence of purified RPA. As shown in Fig. 4D, there
was little to no binding of Xatrip to either (dA)70 or (dA)70-
(dT)70 in the absence of RPA. By contrast, there was efficient
binding of Xatrip to both templates in the presence of RPA.
These properties are similar to those that have been described
for human ATRIP (22).
Role of Xatrip in the Checkpoint-dependent Phosphorylation
of Xchk1—Next, we compared the phosphorylation of Xchk1 in
Xatr-depleted and Xatrip-depleted extracts upon the addition
of (dA)70-(dT)70 (Fig. 5A). As expected, there was no phospho-
rylation of Xchk1 in Xatr-depleted extracts. In Xatrip-depleted
extracts, the phosphorylation of Xchk1 was severely reduced,
but not completely abolished. The phosphorylation of Xchk1
could be largely restored by the addition of recombinant His6-
Xatrip-FLAG to Xatrip-depleted extracts.
To pursue these observations further, we performed time
course experiments (Fig. 5, B and C). In mock-depleted extracts
containing (dA)70-(dT)70, the phosphorylation of Xchk1 began
at 20 min and reached a maximum by 60 min. By contrast, in
Xatrip-depleted extracts, there was no phosphorylation of
Xchk1 at 20 min. However, by 60–90 min, there was significant
phosphorylation of Xchk1 in the absence of Xatrip, but the
extent was still much less than in mock-depleted extracts.
There could be at least two explanations for these observa-
tions. For example, Xatrip could be entirely dispensable in the
phosphorylation of Xchk1, and the reduced phosphorylation of
Xchk1 in Xatrip-depleted extracts could reflect the fact that
there is a significantly less Xatr in these depleted extracts
FIG. 3. Characterization of Xatr and Xatrip in Xenopus egg extracts. A, control (lane 2), anti-Xatr (lane 3), and anti-Xatrip (lane 4)
immunoprecipitates (IP) from egg extracts were immunoblotted for Xatr (upper panel) and Xatrip (lower panel). Lane 1 depicts an initial extract
aliquot. Two additional experiments gave similar results. B, egg extracts containing (dA)70 (A; lanes 1 and 3) or (dA)70-(dT)70 (AT; lanes 2, 4, and
5) were immunoprecipitated with anti-Xatrip (lanes 3 and 4) or control (lane 5) antibodies. The immunoprecipitates were immunoblotted for Xatr
(upper panel) and Xatrip (lower panel). Lanes 1 and 2 depict initial extract aliquots. Two other experiments yielded comparable results.
C, streptavidin-conjugated beads containing no DNA (lane 2), biotinylated (dA)70 (lanes 3 and 5), or biotinylated (dA)70-(dT)70 (lanes 4 and 6) were
incubated for 90 min in egg extracts in the absence (lane 2–4) or presence (lanes 5 and 6) of random sequence complementary 40-mer
oligonucleotides. The beads were washed, subjected to SDS-PAGE, and immunoblotted for Xatr (upper panel), Xatrip (middle panel), and Claspin
(lower panel). Lane 1 depicts an initial extract aliquot. Three independent experiments yielded similar findings. D, Xatr and Xatrip bound
efficiently to short single-stranded DNA. Egg extracts were incubated with magnetic beads containing either no DNA (lane 2) or biotinylated
poly(dA) of the indicated lengths (lanes 3–7). Beads were collected and immunoblotted for Xatr (upper panel) and Xatrip (lower panel). Lane 1
depicts an initial extract aliquot. Two independent experiments gave similar results.
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(30% of the normal level). Another possibility is that Xatrip
has a major role in regulating the phosphorylation of Xchk1 by
Xatr, but that some phosphorylation can occur independently
of Xatrip.
To evaluate these possibilities, we prepared egg extracts
with a reduced concentration of Xatr. For this purpose, we
mixed 7 volumes of Xatr-depleted extract with 3 volumes of
mock-depleted extract (see Fig. 4A). This low Xatr-containing
extract was incubated with (dA)70-(dT)70, and the time course
for phosphorylation of Xchk1 was examined. We observed that
Xchk1 phosphorylation occurred quite well in the low Xatr-
containing extract (Fig. 5, B and C). Although the phosphoryl-
ation of Xchk1 was reduced somewhat relative to that in mock-
depleted extracts, it was clearly more efficient than in Xatrip-
depleted extracts. Therefore, we conclude that the diminished
phosphorylation of Xchk1 in Xatrip-depleted extracts is not
simply due to reduced levels of Xatr. Instead, the presence of
Xatrip is necessary both for stable association of Xatr with
DNA and for fully efficient phosphorylation of Xchk1.
We also examined whether Xatrip is required for the phos-
phorylation of Xchk1 in response to stalled replication forks in
chromosomal DNA (Fig. 5D). To investigate this issue, we
added demembranated sperm nuclei and aphidicolin to mock-
depleted and Xatrip-depleted extracts. As expected, we could
detect the phosphorylation of Xchk1 in response to aphidicolin
in mock-depleted extracts. Moreover, Xatr bound well to chro-
matin in aphidicolin-treated extracts. By contrast, there was no
phosphorylation of Xchk1 in Xatrip-depleted extracts that had
been treated with aphidicolin. Furthermore, there was no de-
tectable binding of Xatr to chromatin in these extracts. These
observations suggest that, if Xatrip is unavailable to recruit
Xatr to stalled replication forks in chromatin, Xatr-mediated
checkpoint signaling does not occur to any detectable extent.
Taken together, these observations show that removal of
Xatrip from egg extracts severely compromised, but did not
completely abolish, the phosphorylation of Xchk1 in response to
(dA)70-(dT)70. By contrast, Xatrip is absolutely required for the
phosphorylation of Xchk1 in response to stalled replication
forks in chromosomal DNA. Since (dA)70-(dT)70 was added at a
high concentration to egg extracts in comparison with the
amount of sperm chromatin in aphidicolin-treated extracts,
transient interaction of Xatr with (dA)70-(dT)70 may be suffi-
cient for some checkpoint signaling. In this case, the implica-
tion would be that Xatrip is not absolutely required for the
phosphorylation of Xchk1 by Xatr. Another possibility is that
there is some as yet unidentified Xatrip-like molecule that can
substitute for Xatrip under some (but not all) circumstances.
Xatr-Xatrip Undergoes a Large Increase in Kinase Activity
upon Association with Specific Nucleic Acid Templates—Previ-
ously, our laboratory presented evidence that Xatr undergoes
activation upon association with DNA in egg extracts (7). Like-
wise, the activity of fission yeast Rad3 increases in response to
DNA damage (25). To pursue these observations further, we set
out to compare the kinase activity of Xatr associated with
model DNA templates that either do or do not elicit the phos-
phorylation of Xchk1. For this purpose, we incubated magnetic
beads that had been coated with either (dA)70-(dT)70 or (dA)70
in egg extracts for 60 min to allow binding of Xatr-Xatrip. At
this point, we re-isolated the beads, incubated them in the
presence of micrococcal nuclease to release Xatr-Xatrip from
the beads, and immunoprecipitated the released Xatr-Xatrip
complex with anti-Xatrip antibodies. Finally, we assayed the
kinase activities of the preparations of Xatr-Xatrip with
PHAS-I as the substrate. Because the yield of Xatr-Xatrip was
higher from (dA)70 than from (dA)70-(dT)70, we adjusted the
assay conditions so that similar concentrations of Xatr-Xatrip
would be present in the incubations.
We observed that the kinase activity of Xatr that was iso-
lated from beads containing (dA)70-(dT)70 was strongly elevated
in comparison with Xatr from (dA)70-coated beads (Fig. 6A). As
a control for the specificity of the assay, we performed a mock
isolation of Xatr-Xatrip from Xatr-depleted extracts. There was
only a background signal in kinase assays of mock samples
from Xatr-depleted extracts, which indicates that the kinase
activity was indeed due to Xatr. Using different amounts of
Xatr-Xatrip in the linear range for the assay, we estimated that
Xatr underwent an 10-fold increase in kinase activity upon
association with (dA)70-(dT)70 versus (dA)70 (Fig. 6, B and C).
We also investigated whether we could detect activation of Xatr
using full-length Xchk1 as the substrate. For this purpose, we
isolated Xatr from beads containing (dA)70 or (dA)70-(dT)70 and
FIG. 4. Xatrip is necessary for the binding of Xatr to DNA. A,
egg extracts (lane 1) were mock-depleted with control antibodies (lane
2) or immunodepleted with either anti-Xatr (lane 3) or anti-Xatrip (lane
4) antibodies. To prepare a low Xatr-containing extract (lane 5), three
parts mock-depleted extract were mixed with seven parts Xatr-depleted
(Xatr) extract. The samples were immunoblotted for Xatr (upper
panel) and Xatrip (lower panel). B, magnetic beads containing no DNA
(lane 1) or biotinylated (dA)70 (A; lanes 2–4) were incubated in un-
treated (lanes 1 and 2), mock-depleted (lane 3), and Xatrip-depleted
(Xatrip; lane 4) extracts. The beads were collected and immunoblotted
for Xatr (upper panel) and Xatrip (lower panel). Two independent ex-
periments yielded similar results. C, magnetic beads containing no
DNA (lane 1) or biotinylated (dA)70-(dT)70 (AT; lanes 2–4) were incu-
bated in untreated (lanes 1 and 2), mock-depleted (lane 3), and Xatrip-
depleted (lane 4) extracts. The beads were collected and immunoblotted
for Xatr (upper panel) and Xatrip (lower panel). Two experiments gave
similar findings. D, recombinant His6-Xatrip-FLAG (lane 1) was incu-
bated with magnetic beads containing no DNA (lanes 2 and 5), biotiny-
lated (dA)70 (pA; lanes 3 and 6), or biotinylated (dA)70-(dT)70 (pA-pT;
lanes 4 and 7) in the absence (lanes 2–4) or presence (lanes 5–7) of
recombinant RPA. The beads were washed and processed for immuno-
blotting with anti-Xatrip antibodies. Three independent experiments
yielded similar results.
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assayed the phosphorylation of full-length recombinant Xchk1-
GST-His6 protein by immunoblotting with anti-phospho-Ser
344
antibodies. By this method, we likewise observed that Xatr under-
went a substantial increase in activity upon association with
(dA)70-(dT)70 in comparison with (dA)70 (Fig. 6D). Consistent with
the observations described above, Xatr that was immunoprecipi-
tated directly from whole egg extracts lacking added DNA dis-
played low basal kinase activity for Xchk1-GST-His6.
In other experiments, we attempted to elute the activated
form of Xatr-Xatrip from (dA)70-(dT)70 by mild salt treatment
prior to immunoprecipitation and measurement of its kinase
activity. We found that Xatr-Xatrip could be eluted from (dA)70-
(dT)70 with salt concentrations as low as 0.2 M NaCl. However,
after immunoprecipitation with anti-Xatrip antibodies, the
salt-eluted Xatr-Xatrip complex displayed low basal kinase
activity (data not shown). This experiment suggests that Xatr
must associate with at least small fragments of nucleic acid
and/or engage in salt-sensitive interactions with another pro-
tein(s) on the DNA to maintain its state of high activity (see
“Discussion”). Alternatively, it is possible that 0.2 M NaCl dis-
rupted the Xatr-Xatrip complex in some manner, but this salt
treatment clearly did not affect the binding of Xatr to Xatrip
(data not shown).
As one step to characterize the requirements for the activa-
tion of Xatr, we asked whether this process depends upon
Claspin. As shown in Fig. 6A, the activation of Xatr occurred
normally in Claspin-depleted egg extracts. Therefore, although
Claspin is essential for the Xatr-dependent activation of Xchk1,
it is not necessary for the initial activation of Xatr on DNA.
Overall, these experiments suggest that, despite the fact that
Xatr-Xatrip can bind very well to single-stranded DNA tem-
plates, interaction with a template containing some double-
stranded character (e.g. (dA)70-(dT)70 and presumably primer-
template DNA at replication forks) is a prerequisite for
activation of Xatr-Xatrip.
Claspin Stimulates Both Autophosphorylation of Xchk1 and
Phosphorylation of Xchk1 by Xatr-Xatrip—To assess the func-
tion of Claspin, we set out to develop a cell-free reaction in
which the activation of Xchk1 might be dependent upon the
presence of Claspin. After exploring a number of different
strategies, we eventually devised the following procedure. We
first prepared forms of recombinant Xchk1 that either con-
tained or lacked associated Claspin. To produce these reagents,
we initially treated egg extracts with (dA)70 or (dA)70-(dT)70.
The latter treatment elicits phosphorylation of the Chk1-bind-
ing domain of Claspin, which enables binding of Xchk1 (13). By
contrast, (dA)70 alone does not stimulate this phosphorylation.
Next, we centrifuged these extracts through Sephadex G-25
columns to remove small molecules, including glutathione and
ATP. Then, we added either recombinant wild-type Xchk1-
GST-His6 or kinase-inactive Xchk1(N135A)-GST-His6 to the
extracts in the presence of EDTA to prevent any further phos-
phorylation reactions. Finally, we used glutathione-agarose to
retrieve the recombinant Xchk1 proteins from the various ex-
tracts. As shown in Fig. 7A, both Xchk1-GST-His6 and
Xchk1(N135A)-GST-His6 from extracts treated with (dA)70-
(dT)70 contained bound Claspin, whereas these proteins from
(dA)70-treated extracts did not contain any Claspin. None of
these preparations contained any detectable Xatr or Xatrip
(data not shown).
We proceeded to incubate the various preparations of recom-
binant Xchk1 with ATP in the absence or presence of immuno-
isolated from the extracts and immunoblotted with anti-Xatr (upper
panel), anti-phospho-Ser344 (middle panel), or anti-Xchk1 (lower panel)
antibodies. Two independent experiments gave similar results.
FIG. 5. Role of Xatrip in the checkpoint-dependent phospho-
rylation of Xchk1. A, shown is the phosphorylation of Xchk1 in vari-
ous extracts. 35S-Labeled Xchk1 was incubated for 60 min in untreated
extract (lanes 1 and 2), mock-depleted extract (lane 3), Xatr-depleted
extract (Xatr; lane 4), Xatrip-depleted extract (Xatrip; lane 5), and
low Xatr-containing extract (lane 6) in the presence of either (dA)70 (A;
lane 1) or (dA)70-(dT)70 (AT; lanes 2–6). These extracts are described in
the legend to Fig. 4A. In a similar experiment, mock-depleted extract
(lanes 7 and 8), Xatrip-depleted extract (lane 9), and Xatrip-depleted
extract to which His6-Xatrip-FLAG had been added back (lane 10) were
incubated with (dA)70-(dT)70 for 0 min (lane 7) or 60 min (lanes 8–10).
All samples also contained 3 M tautomycin. Aliquots of the extracts
were processed for SDS-PAGE and phosphorimaging. B, shown are the
results from time course analysis. The phosphorylation of 35S-labeled
Xchk1 was determined at different times in the indicated extracts
containing (dA)70-(dT)70 as described for A. C, quantitation of the data
in B was performed with ImageQuant software (Amersham Bio-
sciences). Percentages of the upshifted phosphorylated form of Xchk1 in
mock-depleted extract (E), low Xatr-containing extract (‚), Xatrip-de-
pleted extract (), Xatr-depleted extract (Œ), and (dA)70-containing
extract (●) were measured. The points are the mean  S.D. for two
experiments. D, extracts either were not treated with antibodies (lanes
1–3) or were subjected to an immunodepletion procedure with control
(lane 4) or anti-Xatrip (lane 5) antibodies. The extracts were incubated
for 90 min with no nuclei (lane 1), with 3000 sperm nuclei/l (lane 2), or
with sperm nuclei plus aphidicolin (lanes 3–5). Chromatin fractions
(upper panel) and nuclear factions (middle and lower panels) were
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precipitated activated Xatr-Xatrip. The phosphorylation of re-
combinant Xchk1 was monitored by immunoblotting with anti-
phospho-Ser344 and anti-GST antibodies (to detect mobility
shifts of Xchk1). In the absence of Xatr-Xatrip, Xchk1-GST-
His6 that was associated with Claspin displayed an upward
electrophoretic mobility shift indicative of phosphorylation
upon incubation with ATP (Fig. 7B, lanes 1 and 5). This mod-
ification did not take place in the absence of Claspin (Fig. 7B,
lane 4). This shift appears to be due to autophosphorylation
because it did not occur in the case of kinase-inactive
Xchk1(N135A)-GST-His6 that was associated with Claspin
(Fig. 7B, lane 9). Therefore, Claspin appears to stimulate the
autophosphorylation of Xchk1, even in the absence of Xatr-
Xatrip. This observation is reminiscent of the finding that
budding yeast Rad9 stimulates the in vitro autophosphoryla-
tion of Rad53 (33). Upon the addition of Xatr-Xatrip, Xchk1-
GST-His6 and Xchk1(N135A)-GST-His6, both of which lacked
Claspin, became phosphorylated to a limited extent at Ser344,
as indicated by immunoblotting with anti-phospho-Ser344 an-
tibodies (Fig. 7B, lanes 2 and 6). However, in the presence of
Claspin, Xatr was able to phosphorylate both Xchk1-GST-His6
and Xchk1(N135A)-GST-His6 much more efficiently (Fig. 7B,
lanes 3 and 7). Taken together, these results indicate that
Claspin has two distinct effects on Xchk1. In the absence of
Xatr, Claspin stimulates the autophosphorylation of Xchk1.
Moreover, in the presence of Xatr, Claspin also significantly
promotes the phosphorylation of Xchk1 at Ser344 by Xatr.
DISCUSSION
In this study, we have investigated the mechanism by which
Xchk1 undergoes activation during a checkpoint response to
incompletely replicated DNA. In particular, we have evaluated
how Xatr and Claspin collaborate in this process. To pursue
this question, we have identified Xatrip, the regulatory subunit
of Xatr, to use the Xatr-Xatrip complex for these experiments.
We observed that the Xatr-Xatrip complex underwent a
marked elevation of its kinase activity during a checkpoint
response. This activated form of Xatr-Xatrip phosphorylated
Xchk1 efficiently only in the presence of Claspin. These exper-
iments provide direct evidence that Xatr-Xatrip depends upon
the assistance of an additional protein, Claspin, to phosphoryl-
ate a key downstream target effectively. In this role, Claspin
could enhance the fidelity of checkpoint signaling by directing
Xatr-Xatrip to appropriate substrates only under the desired
circumstances.
Role of Xatrip in the Recruitment of Xatr to DNA—We ob-
served that Xatrip could associate with single- and double-
stranded DNA oligonucleotides in a purified system, but that
FIG. 6. Xatr activity is regulated by association with DNA. A, egg extracts either were not treated with antibodies (lanes 1–3) or were
subjected to an immunodepletion procedure with control (lane 4), anti-Xatr (lane 5), or anti-Claspin (lane 6) antibodies. Next, the extracts were
incubated in the presence of magnetic beads containing either biotinylated (dA)70 (A; lane 2) or biotinylated (dA)70-(dT)70 (AT; lanes 1 and 3–6).
The magnetic beads were re-isolated and treated with micrococcal nuclease. The nuclease-released proteins were immunoprecipitated with either
control (lane 1) or anti-Xatrip (lanes 2–6) antibodies. The immunoprecipitates were immunoblotted for Xatr (upper panel) or assayed for kinase
activity toward PHAS-I in the presence of [32P]ATP (lower panel). For activation of Xatr, four independent experiments yielded similar results. For
immunodepletion of Xatr and Claspin, respectively, two independent experiments gave similar results. B, kinase activity was quantitated. Kinase
assays with PHAS-I as the substrate were performed with various amounts of immunoprecipitated Xatr from beads containing (dA)70 (pA; ●) or
(dA)70-(dT)70 (pA-pT; Œ). The amounts of Xatr were quantitated by immunoblotting with detection through enhanced chemiluminescence and
analysis with the STORM system (Amersham Biosciences). The kinase activities and amounts of Xatr are in arbitrary units. C, the average levels
(means S.D.) for the activation of Xatr in four independent experiments were quantitated. D, activated Xatr with full-length Xchk1 was assayed.
Egg extracts lacking added DNA were immunoprecipitated (IP) with control (lane 1) or anti-Xatrip (lane 2) antibodies. In addition, nuclease eluates
from magnetic beads containing (dA)70 (lane 3) or (dA)70-(dT)70 (lane 4) that had been incubated in egg extracts were immunoprecipitated with
anti-Xatrip antibodies. The immunoprecipitates were incubated with recombinant Xchk1-GST-His6 and ATP. After the incubation, the samples
were immunoblotted with anti-Xatr (upper panel) and anti-phospho-Ser344 (lower panel) antibodies. Two independent experiments yielded similar
results.
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this binding depended upon RPA. The binding of Xatr-Xatrip to
the double-stranded DNA template (dA)70-(dT)70 most likely is
due to the fact that some of this template would be annealed
out of register to yield single-stranded regions of DNA. These
observations are consistent with the previous findings of Zou
and Elledge (22) with human ATRIP. On the other hand, more
recent studies have provided evidence that human ATRIP can
also associate with DNA in an RPA-independent manner (34,
35). The reason for the apparently different observations in the
human system is not clear. The RPA-independent mechanism
for binding of ATRIP to DNA appears to be a lower affinity
interaction than that involved in RPA-dependent binding.
Therefore, it is possible that our experimental conditions do not
permit detection of the low affinity RPA-independent mecha-
nism for binding to DNA.
Various studies have indicated that human RPA interacts
with DNA in two modes that occlude 8 and 30 nucleotides,
respectively (36, 37). The 8-nucleotide mode is a low affinity
interaction that involves DNA-binding domains A and B, which
both reside in the largest subunit of RPA (RPA70). In the
30-nucleotide high affinity binding mode, there are additional
contacts with the DNA through binding domains C and D,
which are located in the RPA70 and RPA32 subunits, respec-
tively. Structural studies have demonstrated that the RPA70
subunit can bind to as little as 8 nucleotides of single-stranded
DNA, albeit with low affinity (38). In our study, we have found
that Xatr-Xatrip could associate with single-stranded DNA as
short as 20 nucleotides in length. This observation is consistent
with a model in which one heterotrimeric molecule of RPA can
recruit Xatrip and its associated Xatr subunit to a segment of
single-stranded DNA 20–30 nucleotides in length.
A significant issue is whether ATR interacts with DNA in a
functionally relevant manner in the absence of ATRIP. A num-
ber of studies have reported that either purified ATR or endog-
enous ATR in ATRIP-depleted cells or extracts can bind to DNA
(22, 34, 35, 39). In our study, we have found that, in the absence
of Xatrip, Xatr in egg extracts could not associate detectably
with either model DNA templates (e.g. (dA)70 and (dA)70-(dT)70)
or chromosomal DNA in aphidicolin-treated extracts. However,
we cannot exclude the possibility that Xatr interacts with DNA
in a low affinity mode that cannot be detected under our con-
ditions. The fact that (dA)70-(dT)70 can induce some phospho-
rylation of Xchk1 by Xatr in the absence of Xatrip supports the
possibility that Xatr can interact transiently with this DNA
template under these conditions.
Regulation of ATR and Other Phosphoinositide Kinase-re-
lated Family Members—An important question involves the
issue of how kinases in the phosphoinositide kinase-related
family such as ATR and ATM are regulated during checkpoint
responses. Our study indicates that Xatr undergoes a substan-
tial increase in specific kinase activity during a checkpoint
response. On the other hand, immunoprecipitated ATR from
mammalian cells exposed to various DNA-damaging agents
appears not to exhibit an increase in activity (40). A simple
explanation for the apparent difference would be that ATR
must be physically associated with nucleic acid to maintain its
state of high activity. Therefore, in immunoprecipitation pro-
tocols in which ATR is stripped off the DNA, it may lose kinase
activity as a consequence of the isolation procedure. Consistent
with this possibility, we have found that elution of Xatr-Xatrip
from DNA by mild salt treatment diminished its activity back
to the basal level.
It has also been proposed that ATR might be regulated by a
localization-based mechanism whereby recruitment of ATR to
stalled replication forks would increase its local concentration
greatly in the vicinity of potential substrates (40, 41). Our
results need not contradict this proposal in that concentration
of Xatr at replication forks through binding of Xatrip to RPA-
coated DNA would also be expected to enhance the ability of
Xatr to phosphorylate nearby substrates. Indeed, the two
mechanisms, viz. enhanced activity of Xatr-Xatrip and concen-
tration of this complex near potential substrates, may act syn-
ergistically to promote checkpoint signaling reactions.
Although Xatr-Xatrip binds very well to single-stranded oli-
gonucleotides such as (dA)70, we have shown that single-
stranded templates alone do not elicit the activation of Xatr.
This observation is consistent with our previous report that
(dA)70 does not induce activation of Xchk1 in Xenopus egg
extracts (12). On the other hand, the double-stranded template
(dA)70-(dT)70, which would also contain stretches of single-
stranded regions, is highly effective in inducing the activation
of Xatr. As described previously, (dA)70-(dT)70 triggers the ac-
tivation of Xchk1 in egg extracts very efficiently (12). The
junctions between single- and double-stranded regions in
(dA)70-(dT)70 would resemble primer-template DNA at replica-
tions forks. These junctions would normally be produced by the
synthesis of initiating primers at newly fired replication ori-
FIG. 7. Claspin strongly stimulates the phosphorylation of
Xchk1 by Xatr-Xatrip. A, shown is the retrieval of recombinant
Xchk1-GST-His6 proteins from egg extracts with or without associated
Claspin. Egg extracts were incubated in the presence of (dA)70 (lanes 1
and 3) or (dA)70-(dT)70 plus 3 M tautomycin (lanes 2 and 4). After 60
min, EDTA was added to inhibit kinase activity in the extracts as
described under “Experimental Procedures.” Thereafter, recombinant
wild-type (WT) Xchk1-GST-His6 (lanes 1 and 2) and Xchk1(N135A)-
GST-His6 (lanes 3 and 4) were mixed into the extracts, and the incu-
bation was continued for an additional 60 min. Finally, recombinant
Xchk1-GST-His6 (Xchk1-GH) proteins were re-isolated with glutathi-
one-agarose, and portions were immunoblotted with anti-Claspin (up-
per panel) or anti-GST (lower panel) antibodies. Three independent
experiments gave similar results. B, preparations from A of Xchk1-
GST-His6 (lanes 1–5) or Xchk1(N135A)-GST-His6 (lanes 6–9) contain-
ing (lanes 1, 3, 5, 7, and 9) or lacking (lanes 2, 4, 6, and 8) associated
Claspin were incubated with control (C) immunoprecipitates (lane 1),
Xatr-Xatrip immunoprecipitates (IP; lanes 2, 3, 6, and 7), or no immu-
noprecipitates (lanes 4, 5, 8, and 9) in kinase buffer containing 1 mM
ATP. After 30 min, the samples were processed for immunoblotting
with anti-Xatr (upper panel), anti-phospho-Ser344 (middle panel), or
anti-GST (lower panel) antibodies. Three independent experiments
yielded similar results.
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gins. The implication is that the formation of such structures is
a prerequisite for the activation of Xatr.
A recent study has shown that activation of human ATM in
response to DNA damage involves autophosphorylation at
Ser1981 and dissociation of inactive ATM dimers into monomers
(42). A study on the quaternary structure of human ATR-
ATRIP has indicated that this complex contains one molecule
of each protein (35). However, it seems unlikely that the form
of ATR-ATRIP characterized in that study, which was not
associated with DNA, would be in the fully activated state
corresponding to the one that we have characterized in this
work. It will be interesting to analyze the oligomerization state
of the activated form of Xatr-Xatrip. Significantly, ATM does
not need to remain associated with DNA to display elevated
activity (42), which may not be the case for ATR. An explana-
tion may lie in the differing physiological roles of ATM versus
ATR. For example, DNA damage would sometimes be confined
to very discrete locations in the cell. In such cases, it would
presumably be necessary to signal the presence of damage
throughout the nucleoplasm by dissemination of activated
ATM. On the other hand, ATR may act locally in regions of
single-stranded DNA at replication forks and sites of damage.
Role of Claspin as a Mediator in the Activation of Xchk1—
Our studies have demonstrated that Claspin facilitates the
phosphorylation of Xchk1 by the Xatr-Xatrip complex and also
stimulates the autophosphorylation of Xchk1. These findings
bear out the supposition that Claspin functions as a mediator
protein in checkpoint regulation. Interestingly, although we
have readily observed binding of Xchk1 to Claspin, we have not
been able to detect a complex between Xatr-Xatrip and Claspin.
It could be that Xatr-Xatrip interacts only transiently with
Claspin, during the time that Xatr phosphorylates Xchk1. An-
other possibility is that Claspin acts only upon Xchk1, perhaps
by changing its conformation, to make it a better substrate for
Xatr. Finally, the association of Claspin with stalled replication
forks may concentrate Xchk1 near RPA-bound Xatr-Xatrip
complexes. We do not necessarily expect to detect a complex
between Xatr-Xatrip, Claspin, and Xchk1. In other studies, we
have found that Xchk1 dissociates from Claspin upon activa-
tion (14). Therefore, it appears that Claspin itself may nor-
mally interact only transiently with Xchk1. During this period,
Xchk1 would undergo phosphorylation by Xatr. In human cells,
a complex has been detected between human Claspin and ATR
(43). Furthermore, fission yeast Crb2, which is required for
activation of Chk1 in this organism, binds to Rad3, the homolog
of ATR (44). However, in both of these cases, Claspin and Crb2
bind preferentially to ATR and Rad3, respectively, in the ab-
sence of checkpoint induction. Although there may be some
differences between organisms, these observations nonetheless
support the concept that mediator proteins interact transiently
with other regulators during activation of checkpoint effector
kinases.
Significantly, Claspin does stimulate the autophosphoryla-
tion of Xchk1 in the absence of Xatr. This indicates that
Claspin does not affect Xchk1 solely by facilitating Xatr-cata-
lyzed phosphorylation. Similarly, budding yeast Rad9 stimu-
lates the in vitro autophosphorylation of Rad53 (33). The role of
Mec1, the budding yeast homolog of ATR, in the activation of
Rad53 is unclear. Various observations have indicated that the
C-terminal domain of Chk1 has a negative regulatory role in
suppressing the activity of the N-terminal kinase domain (45–48).
It is possible that activated Claspin could transiently disrupt this
suppressed state and thereby stimulate limited autophosphoryla-
tion of Xchk1. Subsequently, phosphorylation by Xatr may help to
stabilize the activated conformation of Xchk1, which would also
result in more extensive autophosphorylation.
Conclusion—We have shown that Claspin promotes the
phosphorylation of Xchk1 by the activated Xatr-Xatrip complex
in a cell-free reaction. Reconstitution of various checkpoint
signaling reactions in this manner will be necessary to under-
stand these critical processes in molecular detail.
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